Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates.
about
The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cellsSignificant increase in cytotoxic T lymphocytes and natural killer cells by triphala: a clinical phase I studyThe role of NK cells in HIV-1 protection: autologous, allogeneic or both?Evasion from NK cell-mediated immune responses by HIV-1Decreased NK Cell FcRgamma in HIV-1 infected individuals receiving combination antiretroviral therapy: a cross sectional studyLarge scale analysis of phenotype-pathway relationships based on GWAS resultsChanges in cytokine levels and NK cell activation associated with influenza.Multiparametric analysis of host response to murine cytomegalovirus in MHC class I-disparate mice reveals primacy of Dk-licensed Ly49G2+ NK cells in viral control.Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage responseBaseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201).Alcohol suppresses IL-2-induced CC chemokine production by natural killer cells.Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection.Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndromeImmune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 ControllerHuman CD56dimCD16dim Cells As an Individualized Natural Killer Cell Subset.Persistence of Activated and Adaptive-Like NK Cells in HIV+ Individuals despite 2 Years of Suppressive Combination Antiretroviral Therapy.Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individualsCD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infectionA correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllersUnconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicityIn vitro naïve T cell proliferation failure predicts poor post-immunization responses to neoantigen, but not recall antigens, in HIV-infection.Innate immune natural killer cells and their role in HIV and SIV infection.HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing.Association of activating KIR copy number variation of NK cells with containment of SIV replication in rhesus monkeys.Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcomaInnate immune activation in primary HIV-1 infection.Effect of recombinant cytokines on the expression of natural killer cell receptors from patients with TB or/and HIV infection.Differential association of gene content polymorphisms of killer cell immunoglobulin-like receptors with placental malaria in HIV- and HIV+ mothersSubstance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall.HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscapeNK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infectionNatural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infectionNatural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral ActivityAlterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adultsDecreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals.
P2860
Q21144323-EC08B1B8-DBA0-47EC-AB13-3D0359052D14Q21296692-384D64BA-3FA5-4D6C-966D-FE6868D29424Q26753146-94E2E04D-F68D-47F7-8F87-4312126106AFQ26864489-86137981-4D5B-470C-99BB-10205D90838FQ28473151-8DE58D7B-1C4D-4E02-9656-FF8ABEF9FCDEQ28540586-E63F5711-C27D-40E5-B619-9B297BBD69E8Q30407695-CBD608A8-7D0E-4E94-AE3E-EC7A054178E8Q30409829-B08EF490-9C7B-4CF9-88F3-E7A9439CBC4BQ30845033-AFD1B8F2-E349-4AE5-8B75-1B0868994AA5Q33508241-272F161F-6D9D-44ED-846D-20CF2F76DD1AQ33572705-50A376CA-2EE1-46BF-B9C4-19BC577AB961Q33586473-EB9DB363-22CB-453E-81C6-1F082C5D2BEDQ33686528-4AE63109-C20D-41C6-97CF-2A8FD7F95D10Q33752757-FB50CC55-C8C3-4732-B55E-4265A1C9F569Q33772422-C6D45CAE-1BE0-4ED4-AAC7-64B8CD178100Q33809708-A4CA3E62-1E99-4582-ACB5-13F510DEA8BFQ33810001-A8285EF5-AA2C-411F-8213-C1A60715EA08Q33854427-E4DFBB24-200B-48F5-A61B-98C28AE298E1Q33864775-A9E382B7-C645-4F5C-A009-3A2DF0731930Q33896743-022F1EF6-57B3-4CB5-9D7F-017B0245C644Q33982102-EF60842C-E60F-43E3-9EDE-9483EEE41845Q34037685-2B92A5BF-6ED0-493F-9DA9-5863A0D387FAQ34050143-57E95CEE-0B09-41B2-AB1F-C0CC5987791BQ34070433-53695CE4-48C6-48F2-AFD6-38C72AC0E957Q34087997-5CC6DB07-438F-4615-A661-FB8A5E2359B6Q34109760-9AA32CFF-1908-4092-9C23-C7DC4E9D6D30Q34130226-68F9485F-172C-4B17-8937-C7C857F554C2Q34155538-078CA581-3CC4-41F2-9DDA-249F5968265BQ34310216-1571CEAF-FEE6-4CEF-94AB-2221140B13D8Q34310322-CA7BC47D-74A4-4323-8F4B-D8D49472A7E5Q34417546-DAABB525-85D2-4FF6-A7FD-6B4DED615B6EQ34434825-BB1D931D-B95D-4471-92F8-91F0A8063DE9Q34671009-D35DDFFF-729A-4D19-A185-DE6AA7F363F4Q34680046-DD3BCB34-84A0-4C89-AEF2-7371E4A819D2Q34694776-AD6A075F-4EF9-4702-9D19-6FB6160132E3Q34741864-CAD7B826-9BB0-4C6D-AD5D-6D703FE223ECQ34774226-831B30B6-752A-4EBF-887E-F8F4DF545B2FQ34785742-D290636C-7165-4AEA-8FE6-F0731ED2CEBCQ35034531-EFA14EF2-724B-428A-8582-EB66472B707FQ35037803-692296AB-D46F-45CF-BD8F-5EC0E8A9CAC0
P2860
Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Natural killer cells in HIV-1 ...... d their functional correlates.
@ast
Natural killer cells in HIV-1 ...... d their functional correlates.
@en
Natural killer cells in HIV-1 ...... d their functional correlates.
@nl
type
label
Natural killer cells in HIV-1 ...... d their functional correlates.
@ast
Natural killer cells in HIV-1 ...... d their functional correlates.
@en
Natural killer cells in HIV-1 ...... d their functional correlates.
@nl
prefLabel
Natural killer cells in HIV-1 ...... d their functional correlates.
@ast
Natural killer cells in HIV-1 ...... d their functional correlates.
@en
Natural killer cells in HIV-1 ...... d their functional correlates.
@nl
P2093
P2860
P50
P356
P1476
Natural killer cells in HIV-1 ...... d their functional correlates.
@en
P2093
Alessandro Moretta
Emanuela Marcenaro
Gabriella Lombardo
Janet Benjamin
Lorenzo Moretta
Marie A Planta
Marybeth Daucher
P2860
P304
15011-15016
P356
10.1073/PNAS.2336091100
P407
P577
2003-11-25T00:00:00Z